We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Long-Term Risk for CVD Stratified by Fasting Glucose Level

By LabMedica International staff writers
Posted on 31 Jan 2019
Cardiovascular disease (CVD) refers to any disease of the heart, vascular disease of the brain, or disease of the blood vessel. More...
The most prevalent cardiovascular diseases include coronary heart disease (CHD) such as a heart attack and cerebrovascular disease such as a stroke.

Middle-aged adults who experience an increase in fasting glucose level into the range for diabetes have an elevated 30-year risk for coronary heart disease and stroke compared with their peers with normal blood glucose levels. It has also been reported that an increased long-term CVD risk for middle-aged men with fasting glucose in the prediabetes range.

Scientists at Wake Forest School of Medicine (Winston-Salem, NC, USA) and their colleagues pooled data from seven observational cohorts that included both white and black adults. They estimated the long-term risk for CVD based on fasting glucose levels both below and above the threshold for diabetes (7 mmol/L or 126 mg/dL). Combined, the seven cohorts followed participants from 1960 to 2015. A total of 19,630 participants (56.1% women; 31.6% black) at an index age of 55 years were included. The team created five stratifications for fasting glucose levels: less than 5 mmol/L, between 5 mmol/L and 5.5 mmol/L, between 5.6 mmol/L and 6.2 mmol/L, between 6.3 mmol/L and 6.9 mmol/L (prediabetes) and more than 7 mmol/L (diabetes). CVD was defined as CHD, myocardial infarction and fatal and nonfatal stroke.

The investigators reported that the risk for CVD through 85 years of age ranged from 15.3% (<5.0 mmol/L) to 38.6% (diabetes levels) among women and from 21.5% (5.0–5.5 mmol/L) to 47.7% (diabetes levels) among men. A fasting glucose (FG) of 6.3–6.9 mmol/L was associated with higher long-term CVD risk compared with the lowest FG among men, but not women. Increases in glucose during midlife with conversion to diabetes were associated with higher cardiovascular risk (1.3- to 3.6-fold) than when increasing glucose below the diabetes threshold.

Michael P. Bancks, PhD, an assistant professor of Endocrinology and lead author of the study said, “The study shows the importance of preventing or delaying the development of diabetes in order to prevent the development of cardiovascular disease. Our study included a large number of African-Americans and people from geographically diverse areas of the USA, so our findings can be generalized to a much broader USA audience than the prior work.” The study was published in the January 2019 issue of the journal Diabetes Care.

Related Links:
Wake Forest School of Medicine


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.